期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Analysis of known point mutations and SNPs in genes responsible for monogenic Parkinson’s disease in Russian patients
1
作者 Elena V. Filatova Maria I. Shadrina +4 位作者 Ekaterina Y. Fedotova Irina a. Ivanova-Smolenskaya Sergei N. Illarioshkin svetlana a. limborska Petr a. Slominsky 《Advances in Parkinson's Disease》 2013年第1期28-30,共3页
Background: Parkinson’s disease (PD) is caused by complex interactions between genetic and environmental factors. Mendelian forms of PD rarely occur in practice, but respective genes may play some role in pathogenesi... Background: Parkinson’s disease (PD) is caused by complex interactions between genetic and environmental factors. Mendelian forms of PD rarely occur in practice, but respective genes may play some role in pathogenesis of a common sporadic form of the disease. Methods: We analyzed most frequent known point mutations (PMs) and single-nucleotide polymorphisms (SNPs) in genes responsible for monogenic PD in 408 Russian patients, using arrayed primer extension (APEX), real-time PCR, and restriction fragment length polymorphism analysis. Results: We detected only three heterozygous PMs in the PARK2 gene in three non-related patients with early-onset sporadic PD. No association between PD and the studied SNPs was identified. Conclusion: The examined PMs and SNPs in genes responsible for monogenic PD do not contribute significantly to the development of sporadic PD in Russia. 展开更多
关键词 Parkinson’s Disease Point Mutations Single-Nucleotide POLYMORPHISMS
下载PDF
Transcriptome profiling of 6-OHDA model of Parkinson’s disease
2
作者 Maria I. Shadrina Elena V. Filatova +5 位作者 anelya Kh. alieva alla V. Stavrovskaya Rudolph M. Khudoerkov svetlana a. limborska Sergei N. Illarioshkin Petr a. Slominsky 《Advances in Bioscience and Biotechnology》 2013年第6期28-35,共8页
Analysis of monogenic forms and candidate genes of Parkinson’s disease (PD) does not allow to describe completely the contribution of genetic factors to the etiopathogenesis of the disorder. An approach associated wi... Analysis of monogenic forms and candidate genes of Parkinson’s disease (PD) does not allow to describe completely the contribution of genetic factors to the etiopathogenesis of the disorder. An approach associated with an analysis of changes in a transcriptome pattern during the development of the disease in model objects can be used to identify new candidate genes that are involved in the pathogenesis of PD. In this work, we performed a transcriptome analysis of a PD model, created via stereotaxic unilateral introduction of the 6-hydroxidopamine (6-OHDA) into the substantia nigra pars compacta (SNpc) of a rat brain, to identify new candidate genes for PD. We studied transcriptome alterations in the substantia nigra of the rat brains 2 weeks after toxin administration, when the rats developed the Parkinson-like phenotype, and 4 weeks after toxin administration, when maximal changes in the behavior of animals were observed. The transcriptome analysis of the substantia nigra of the rat brains at the first time point (2 weeks) revealed changes in expression of genes that were clustered with high significance (p < 0.01, modified Fisher extract p value) into three metabolic pathways according to protein participation: modification of the extracellular matrix, signal transduction (including genes encoding signal peptides), and inflammation processes. This likely indicates that, during this time nonspecific effects associated with the response to surgery took place in the substantia nigra of the rats. Concomitantly, the situation changed dramatically and a response associated with damage to the nervous tissue was observed 4 weeks after neurotoxin administration. As a result, we identified five metabolic pathways containing predominantly genes, that encode protein products that are involved in the processes of neuron projection, normal functioning of the soma and dendrites of neurons, synaptic transmission, and transmission of nerve impulses (p < 0.01, modified Fisher extract p value). 展开更多
关键词 6-OHDA Parkinson’s DISEASE TRANSCRIPTOME
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部